CLASS III Device recall · Reported 8 Aug 2012 · FDA Enforcement Report

IRISpec" CA/CB two-part urine chemistry control twin set recalled

Iris Diagnostics is recalling IRISpec" CA/CB two-part urine chemistry control twin set, Iris Diagnostics, distributed nationwide in the US. The recall was initiated on 9 Jul 2012 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesIris Diagnostics part number 800-0074, lot number 131-12.
Quantity recalled862

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2124-2012
FDA event ID
62555
Recalling firm
Iris Diagnostics, Chatsworth, CA
Classification
Class III
Status
Terminated
Recall initiated
9 Jul 2012
FDA classified
1 Aug 2012
Reported
8 Aug 2012
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Device type
Patient Monitors

Timeline

9 Jul 2012Recall initiated by company
1 Aug 2012Classified by FDA+23 days
8 Aug 2012Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

IRISpec" CA/CB two-part urine chemistry control twin set, Iris Diagnostics part number 800-0074. Intended Use: IRISpec CA/CB is an assayed QC material for monitoring of the urine chemistry analytes and devices as listed on the package insert. For in vitro diagnostic (IVD) use only.

Where it was distributed

Nationwide Distribution

Nationwide

Questions about this recall

Why was it recalled?

The firm recalled after it received complaints of IRISpec CA/CB two part Urine Chemistry Control, 101131-12, where the nitrite results read negative for the part B control, which should be positive.

Which lots are affected?

Iris Diagnostics part number 800-0074, lot number 131-12.

Where was it sold?

Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Iris Diagnostics

All 4

Other Patient Monitors recalls

All 1,022